Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by Eoganachton Aug 03, 2022 11:49am
362 Views
Post# 34868280

RE:RE:Next Quarterly News Letter !

RE:RE:Next Quarterly News Letter !Hi Dawg - I think they may be going back to quarterly newletters, as creating them was part of the job description of Akanksha Dhingra, the new Public Relations / Investor Relations Coordinator Theralase hired.

"In conjunction with the finance department, research, compile and write effective press releases and quarterly newsletters on material corporate matters and obtain written authorization from pertinent stakeholders, senior management and the corporate disclosure committee to publicly release."

DJDawg wrote:
I'm pretty sure they don't do quarterlies anymore. They just do random press releases and quarterly financial releases. Note that the last official quarterly newsletter is dated Nov 2021. In a way I'm glad for it as I think some people can manipulate more if they know there is a semi-predictable event to work off of. If they are just going to release random updates I think it makes that strategy less effective.


<< Previous
Bullboard Posts
Next >>